Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

July 24, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 Symbol: MAXHEALTH Scrip Code: 543220 Sub.: Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, This is in continuation to our earlier intimations dated May 19, 2026 and July 8, 2026, wherein we had informed about the petitions, including interlocutory petition, filed before the Hon'ble National Company Law Tribunal, Cuttack Bench by the legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Ltd. ("KHL"), a subsidiary of the Company, the other shareholder of KHL from whom the Company acquired the majority equity stake and the Company. The said petitions were listed on July 23, 2026 at 2.30 pm (IST). Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure Details with respect to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Particulars Details 1. The details of any change in the status and The Hon’ble National Company Law Tribunal, Cuttack Bench has / or any development in relation to such adjourned the matter to August 4, 2026 for further hearing. proceedings 2. In the case of litigation against key Not applicable management personnel or its promoter or ultimate person in control, regularly provide details of any in the status and / or any development in relation to such proceedings 3. In the event of settlement of the Not applicable proceedings, details of such settlement including - terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity